Fungal Genomics & Biology

Fungal Genomics & Biology
Open Access

ISSN: 2165-8056

Research Article - (2018) Volume 8, Issue 1

Acetylcholine Induces Yeast to Hyphal Form Transition in Candida albicans

Ali A and Karuppayil SM*
School of Life Sciences, Swami Ramanand Teerth Marathwada University, India
*Corresponding Author: Karuppayil SM, Former Director, School of Life Sciences, Swami Ramanand Teerth Marathwada University, India, Tel: +919764386253 Email:

Abstract

Background: In Candida albicans, yeast to hyphal form transition can be induced by serum, proline, glucose, and N-acetylglucosamine. Acetylcholine is a neuromodulator which can stimulate both muscarinic and nicotinic acetylcholine receptors in humans. In this study, we are reporting that acetylcholine can induce yeast to hyphal form transition in C. albicans. The adenylyl cyclase inhibitor, MDL 12, 330A inhibited this transition indicating the role of cAMP. Muscarinic receptors in C. albicans did not report yet. We have reported that C. albicans Rrp9 exhibits identity and similarity with the human muscarinic receptor M1. In humans, activation of muscarinic M1 receptor can produce cAMP through inositol phosphate pathway. The inositol phosphate pathway in C. albicans is already known. We have carried out the local and global alignment sequences between the proteins of humans and C. albicans which are involved in inositol phosphate pathway. We found considerable identities and similarities between them. Herein, we hypothesize that acetylcholine may activate Rrp9 which may lead to activation of inositol phosphate signaling pathway in C. albicans. This study suggests that Rrp9 may have a potential role in yeast to hyphal form transition in C. albicans.

Keywords: Morphogenesis, Acetylcholine, Muscarinic receptors, cAMP, Inositol phosphate pathway, Bioinformatics

Introduction

Communication and sensing processes in eukaryotic cells are governed by their surrounding environment. The first step in sensing of signaling molecules or ligands depends on a receptor [1]. The signal molecule or ligand may bind with its receptor leading to intracellular responses that involve many physiological and biological events [2]. Acetylcholine is a neurotransmitter secreted from nerve cells to send signals to other cells. Acetylcholine stimulates both muscarinic and nicotinic acetylcholine receptors [3]. Muscarinic acetylcholine receptors are typical G-protein coupled receptors that mediate various important physiological and biological functions according to their location and subtype [4]. Five distinct muscarinic receptor subtypes (M1-M5) are known in humans [5]. M1, M3, and M5 receptors can couple with Gαqprotein and stimulate the inositol phosphate pathway. The M2 and M4 receptors act via Gαi-protein to inhibit adenylyl cyclase which results in reducing of intracellular cAMP production [6]. In Candida albicans, the essential protein, Rrp9 is reported to exhibit identity and similarity with human muscarinic M1 receptor [7]. Activation of human muscarinic M1 receptor can produce cAMP through inositol phosphate pathway. After binding with an agonist, acetylcholine, the activated muscarinic M1 receptor couples with Gq subunit type of heterotrimeric G-alpha protein which leads to stimulation of phosphlipase C (PLC) through inositol phoaphate pathway. The enzyme, phospholipse C can hydrolyze the phospholipid, phosphatidylinositol 4, 5-bisphosphate (PIP2) into diacyl glycerol (DAG) and inositol 1, 4, 5-trisphosphate (IP3). DAG and IP3 are second messengers that regulate diverse cellular processes in human cells. IP3 diffuses through the cytosol to binding with IP3 receptors of calcium channels in the smooth endoplasmic reticulum (ER) to release calcium into cytoplasm. Calcium involved in signal transduction which can catalyze calmodulin (caM) to stimulate adenylyl cyclase production. Adenylyl cyclase produces cAMP from ATP. On the other hand, DAG can activate protein kinase C and in turn stimulate adenylyl cyclase to form cAMP [8-10]. Production of cAMP is involved in many intracellular activities like cell growth, regulation of cell proliferation, skin cell signaling and immune responsiveness [11-15], learning and memory processes [16,17]. Morphogenesis in C. albicans is considered as a good model system for studying eukaryotic cell differentiation. In C. albicans , yeast to hyphal form transition can be induced by various external signals such as serum, neutral pH, high temperature, contact, glucose, proline, N-acetyglucosamine, CO2, and starvation [18-26]. Yeast to hyphal form transition involves many signaling pathways such as cAMP-PKA and Mitogenic-activated protein (MAP) kinase pathways [27,28]. In this study, acetylcholine can induce yeast to hyphal form transition in C. albicans and the mechanism of induction is hypothesized.

Materials and Methods

Chemicals and Media

Acetylcholine chloride was purchased from TCI chemicals Pvt. Ltd., India. Adenylyl cyclase inhibitor, MDL 12,330A was purchased from Sigma-Aldrich, India. Microtitre plates and other media were purchased from HiMEDIA Chemicals Ltd., Mumbai, India

Culture of Candida albicans

Candida albicans (ATCC 90028) was obtained from the Institute of Microbial Technology (IMTECH) Chandigarh, India. The culture was maintained on Yeast extract -Peptone –Dextrose (YPD) agar slant at 4°C and propagated by inoculating a single colony from the YPD agar plates (Yeast extract 1%, Peptone 2%, Dextrose 2 and Agar 2.5) into 50 ml YPD broth in a 250-ml conical flask. Flasks were incubated overnight at 30ºC at 100 rpm on an orbital shaking incubator. The cells were harvested by centrifugation at 2000 rpm and washed thrice with sterile 0.1 M Phosphate-Buffered Saline (PBS), pH 7.4 and the cell density was determined by a haemocytometer count. Finally cells were suspended in sterile PBS.

Yeast to hyphal form transition

Yeast to hyphal form transition assay was carried out in 96-well microtitre plates [29]. C. albicans cells stock was diluted to 1 × 106 cells/ ml in PBS buffer. Various concentrations of acetylcholine chloride were prepared and were added in each well. Wells without acetylcholine were kept as control. The final volume was kept at 200 μl in each well. Triplicate wells were run. The microtitre plates were incubated at 37°C at 120 rpm on an orbital shaker incubator for 2 h. After incubation period, the cells were observed microscopically by using an inverted light microscope (Metzer, India). Hundred cells were counted and numbers of yeast and hyphal forms were noted. Three counting were taken. The main value was used to determine hyphal form formation.

Inhibition of morphogenesis

C. albicans cells stock was diluted to 1 × 106 cells/ml in 1% of acetylcholine chloride. Various concentrations of adenylyl cyclase inhibitor, MDL 12,330A were prepared and ranged 200 – 3.1 μg/ml and were added in each well. Wells without MDL 12,330A were kept as a control. The final volume was kept at 200 μl in each well. The microtitre plates were incubated at 37ºC at 120 rpm on shaking incubator for 3 h. After incubation period cells were observed microscopically by using inverted light microscope (Metzer, India). The concentration which inhibited hyphae formation by ≥50% was compared to the control and was considered as the Minimum inhibitory concentration (MIC) for morphogenesis. All experiments were done in triplicate.

Bioinformatics study

The local and global alignment sequences between human and Candida albicans proteins involved in inositol phosphate pathway.

The FASTA sequences of human proteins Guanine nucleotidebinding protein G (q) subunit alpha (Gαq protein), Calmodulin (caM), Protein kinase C theta type (PKC-θ), Protein kinase C epsilon type (PKCε), Phospholipase C gamma types 1 & 2 (PLCG1 and PLCG2), Phospholipase C delta types 1, 3 & 4 (PLCD1, PLCD3, and PLCD4) and Phospholipase C β1 were retrieved from Uniprot database with accession numbers of P50148, P62158, Q04759, Q02156, P19174, P16885, P51178, Q8N3E9, Q9BRC7 and Q9NQ66 respectively. The FASTA sequences of Candida albicans proteins G protein alpha subunit (Gpa2), Calmodulin (caM), Phospholipase C1 (PLC1), Protein kinase C-like 1( PKC1) were obtained from Uniprot database with accession numbers of A0A1D8PJG1, P23286, O13433 and P43057 respectively. The alignment was carried out between human and C. albicans proteins by using Smith-waterman method for local alignment and by using Needleman-Wunsch method for global alignment as follows:

• Between G protein alpha subunit (Gpa2) (A0A1D8PJG1) from C. albicans and human Gαq protein (P50148).

• Between Calmodulin (caM) (P23286) fromC. albicans and human Calmodulin (caM) (P62158).

• BetweenC. albicans PLC1 (O13433) and human PLCG1 (P19174), PLCG2 (P16885), PLCD1 (P51178), PLCD3 (Q8N3E9), PLCD4 (Q9BRC7) and Phosphlipase C β1 (Q9NQ66) separately.

• Between C. albicans PKC1 (P43057) and human PKC-θ (Q04759) and PKCε (Q02156) separately.

Statistical analysis

Values of samples were compared by using Student’s t-test. A value of P < 0.05 was considered statistically significant.

Results

Acetylcholine induces yeast to hyphal form transition inC. albicans

Acetylcholine induced yeast to hyphal form transition in C. albicans (ATCC 90028) after 2 h. At concentration of 1% of acetylcholine, hundred percentages of hyphal formation was showed (Figure 1a, 2a). A 95%, 85%, 80% and 35% of yeast to hyphal form transition was showed at concentrations of 0.5%, 0.25%, 0.125% and 0.062% respectively. At concentration of 0.031% of acetylcholine, 15% of hyphal formation was showed.

Adenylyl cyclase inhibitor, MDL 12,330A inhibits yeast to hyphal formation induced by acetylcholine in C. albicans

The human adenylyl cyclase inhibitor, MDL 12,330A inhibited yeast to hyphal form transition at 12.5 μg / ml and above this concentration. Fifty percentage of hyphal formation was inhibited at 6.2 μg / ml and considered as the Minimum inhibitory concentration (MIC) (Figure 1b, 2b).

fungal-genomics-hyphal-transition

Figure 1a: Acetylcholine inducing of yeast to hyphal form transition in Candida albicans at 37ºC after 2h.

fungal-genomics-cyclase-inhibitor

Figure 1b:Effect of adenylyl cyclase inhibitor, MDL 12,330A on acetylcholine induced yeast to hyphal formation in Candida albicans (ATCC 90028).

fungal-genomics-Candida-albicans

Figure 2a:Acetylcholine induces yeast to hyphal form transition in Candida albicans; A) Control; B) 0.015%; C) 0.062%; D) 0.031%; E) 0.125%; F) 0.25%; G) 0.5%; H) 1%.

fungal-genomics-yeast-hyphal

Figure 2b:Effect of adenylyl cyclase inhibitor, MDL 12,330A on acetylcholine induced yeast to hyphal formation in Candida albicans (ATCC 90028). A) Control; B) 3.1μg/ ml C) 6.2μg/ml; D) 12.5μg/ml; E) 25μg/ml; F) 50μg/ml; G) 100μg/ml; H) 200μg/ml.

Proteins of humans and Candida albicans which are involved in the inositol phosphate pathway share significant identities and similarities.

Local alignments: The local alignment between human Gαq protein andC. albicans G protein alpha subunit (Gpa2) showed that human Gαq protein has 38 identity and 56 similarity with C. albicans G protein alpha subunit (Gpa2) at the amino acid level at an overlap of 370 amino acids (Table 1 and Figure 3a). The local alignment between human calmodulin (caM) and C. albicans calmodulin (caM) showed that the human calmodulin (caM) has 71 identity and 89 similarity to C. albicans calmodulin (caM) at an overlap of 149 amino acids (Table 1). The local alignment between, human Protein kinase C epsilon type (PKCε) and Candida albicans protein kinase C-like 1(PKC1) revealed that human PKCε has 35 identity and 51 similarity to C. albicans PKC1 at an overlap of 757 amino acids (Table 1). Also, the local alignment between human protein kinase C theta type (PKC-θ) and C. albicans PKC1 showed that human PKC-θ has 34 identity and 54 similarity to C. albicans PKC1 at an overlap of 756 amino acids (Table 1). The local alignment between human Phospholipase C delta types (PLCD1, PLCD3, and PLCD4) and C. albicans Phospholipase C1 (PLC1) represented that human PLCD1and PLCD3 have 30 identity with similarities 49 and 47 respectively to C. albicans PLC1 at an overlap of 699 and 634 amino acids respectively, the human PLCD4 also has 33 identity and 48 similarity with C. albicans PLC1 at an overlap of 635 amino acids (Table 1). The local alignment between human Phospholipase C gamma types (PLCG1and PLCG2) to C. albicans PLC1 revealed that human PLCG1 has 42% identity and 61 similarity with C. albicans PLC1 at amino acids level of 159 amino acids, while PLCG2 has 44 identity and 61% similarity to CaPLC1 at an overlap of 159 amino acids (Table 1). The local alignment between human Phospholipase C beta 1(PLCβ1) and C. albicans PLC1 showed that C. albicans PLC1 has 36 identity and 55 similarity with human PLCβ1 at an overlap of 363 amino acids (Table 1 and Figure 3b).

Human   Protein names Candida albicans
G-protein alpha subunit (Gpa2) PKC1 Calmodulin       (caM) (PLC1)
  Identity  %   Similarity % A.As  overlap Identity % Similarity % A.As  overlap Identity % Similarity % A.As overlap Identity% Similarity
%
A.As  overlap
Gαq-protein 38 56 370                  
PKC-θ   34 54 756            
PKCε   35 51 757            
Calmodulin (caM)     71 89 149      
PLCD1       30 49 699
PLCD3       30 47 634
PLCD4       33 48 635
PLCG1       42 61 159
PLCG2       44 61 159
PLCB1       36 55 363

Table 1: Local alignment between humans and Candida albicans proteins which are involved in the inositol phosphate pathway.

fungal-genomics-amino-acid

Figure 3a:Pairwise alignment between amino acid sequences of Candida albicans Gαq (CaGpa2) and human Gαq-protein (HGαq) showing 38 % identity and 56 % similarity.

fungal-genomics-sequences-Candida

Figure 3b:Pairwise alignment between amino acid sequences of Candida albicans PLC1 (CaPLC1) and human PLCB1 (HPLCB1) showing 36 % identity and 55 % similarity.

Global alignments: The global alignment between human Gαq protein and C. albicans G protein alpha subunit (Gpa2) showed that human Gαq protein has 30 identity and 45 similarity with C. albicans G protein alpha subunit (Gpa2) at the amino acid level at an overlap of 505 amino acids (Table 2). The global alignment between human calmodulin (caM) and C. albicans calmodulin (caM) showed that the human calmodulin (caM) has 71 identity and 89 similarity with C. albicans calmodulin (caM) at an overlap of 149 amino acids (Table 2 and Figure 3c). The global alignment between human Protein kinase C epsilon type (PKCε) and C. albicans Protein kinase C-like 1(PKC1) revealed that human PKCε has 27 identity and 42 similarity with C. albicans PKC1 at an overlap of 1118 amino acids (Table 2 and Figure 3d). Also, the global alignment between human Protein kinase C theta type (PKC-θ) and C. albicans PKC1 showed that human PKC-θ has 27 identity and 40 similarity with C. albicans PKC1 at an overlap of 1115 amino acids (Table 2). The global alignment between human Phospholipase C delta types (PLCD1, PLCD3, and PLCD4) and C. albicans Phospholipase C1 (PLC1) showed that human PLCD1 and PLCD4 have 25 identity with similarities of 39 and 38 respectively to C. albicans PLC1 at an overlap of 1119 and 1118 amino acids respectively (Table 2), while human PLCD3 has 24 identity and 40 similarity with CaPLC1 at an overlap of 1111 amino acids (Table 2). The global alignment between human Phospholipase C gamma types (PLCG1and PLCG2) with C. albicans PLC1 revealed that human PLCG1and PLCG2 have 21 identity with similarities of 36 and 37% respectively to CaPLC1 at an overlap of 1403 and 1360 amino acids respectively (Table 2).

Discussion

In this study, effect of acetylcholine on C. albicans morphogenesis is tested. Acetylcholine induced yeast to hyphal form transition in a concentration dependent manner (Figure 1a and Figure 2a). The adenylyl cyclase inhibitor, MDL 12,330A inhibited this transformation (Figure 1b and Figure 2b) indicating the role of cAMP. In C. albicans , cAMP-mediated signaling pathway is involved in the yeast-to-hyphal form conversion [30]. Muscarinic receptors in C. albicans are not reported to exist. Rrp9 protein in C. albicans is reported to exhibits identity and similarity with human muscarinic M1 receptor [7]. Acetylcholine also is reported to binds with Rrp9 protein [31]. In humans, activation of muscarinic M1 receptor leads to production of cAMP through inositol phosphate pathway. The inositol phoaphate pathway in C. albicans is reported to exist. Roy and Datta showed that calmodulin inhibitor, trifluoperazine (TFP) inhibited yeast to germ tube formation of C. albicans induced by N-acetylglucosamine [32]. Trifluoperazine (TFP) is known to be a protein kinase-C inhibitor [33]. Gadd and Foster found that inositol 1, 4, 5-trisphosphate (IP3) was produced during yeast form and germ tube formation in C. albicans [34]. Sato et al. found that hyphae formation in C. albicans grown on Sabouraud’s medium containing 10 FBS was inhibited by calmodulin inhibitor, (TFP or W-7) and adenylyl cyclase inhibitor MDL 12,330A [35]. They also found that the relative expressions of hyphae-specific mRNAs of ALS3, ALS8 in C. albicans were inhibited by the addition of TFP and MDL-12-330A [35]. The expression of adhesion proteins, AL3 and ALS8 was also controlled by the RAS-cAMP pathway [36,37]. These findings suggest that the Ca2+/calmodulin signal pathway is associated with the RAS-cAMP pathway which regulates the transformation of C. albicans cells. The second messengers, cAMP and Ca2+ - CaM can transmit their effect through various cellular signalling pathways [38]. When a muscarinic M1 receptors is activated by acetylcholine. This is lead to production of cAMP via inositol triphospate pathway. The bioinformatics study showed considerable identities and similarities between the proteins of humans and C. albicans which are involved in the inositol phosphate pathway (Tables 1 and 2; Figure 3(a-d)). Herein, it is hypothesized that acetylcholine may induce yeast to hyphal form conversion in C. albicans through inositol phosphate pathway by activation of muscarinic M1 receptor like protein, Rrp9. Activation of Rrp9 by acetylcholine in C. albicans may couple to Gα-protein (CaGpa2) which can lead to stimulation of C. albicans phospholipase C1 (CaPLC1) via inositol phosphate pathway. Phospholipase C (CaPLC1) may hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2) into diacyl glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG may stimulate C. albicans protein kinase-C1 (CaPKC1) that leads to activation of C. albicans adenylyl cyclase (CDC35) for producing cAMP. Also, IP3 in turn stimulates the releasing of calcium from cytosol into cytoplasm to couple with C. albicans calmodulin (caM) for activation of adenylyl cyclase (CDC35) which leads to production of cAMP (Figure 4). This pathway may produce cAMP that may induce yeast to hyphal form transition and this transition can be inhibited by adenylyl cyclase inhibitor, MDL 12,330A (Figure 4). This study suggests that C. albicans Rrp9 may have a potential role in C. albicans morphogenesis.

fungal-genomics-calmodulin-human

Figure 3c:Pairwise alignment between amino acid sequences of Candida albicans calmodulin (Ca-caM) and human calmodulin (H-caM) showing 71 % identity and 89 % similarity.

fungal-genomics-human-PKCε

Figure 3d:Pairwise alignment between amino acid sequences of Candida albicans PKC1 (CaPKC1) and human PKCε (HPKCε) representing 27% identity and 42% similarity.

fungal-genomics-receptor-agonist

Figure 4.A hypothetical model for the mechanism action of muscarinic receptor agonist, acetylcholine and adenylyl cyclase inhibitor, MDL 12,330A on Candida albicans (ATCC 90028) morphogenesis. We hypothesize that acetylcholine induces yeast to hyphal form transition by activating the muscarinic M1 receptor like protein, CaRrp9. Activated CaRrp9 stimulates C. albicans adenylyl cyclase (CDC35) through inositol phosphate signaling pathway, while adenylyl cyclase inhibitor, MDL 12,330A inhibits this transformation by blocking adenylyl cyclase.

Human   Protein names Candida albicans
G-protein alpha subunit (Gpa2) PKC1 Calmodulin       (caM) (PLC1)
Identity   % Similarity % A.As overlap Identity % Similarity % A.As overlap Identity % Similarity % A.As overlap Identity% Similarity
%
A.As
overlap
Gαq-protein 30 45 505                  
PKCQ   27 40 1115            
PKCE   27 42 1118            
Calmodulin (caM)     71 89 149      
PLCD1       25 39 1119
PLCD3       24 40 1111
PLCD4       25 38 1118
PLCG1       21 36 1403
PLCG2       21 37 1360
PLCB1       21 32 1498

Table 2: Global alignment between humans and Candida albicans proteins which are implicated in the inositol phosphate pathway.

Conclusion

The neurotransmitter, acetylcholine can activate muscarinic M1 receptor through inositol phosphate pathway which leads to cAMP production. In humans, the second messenger cAMP is implicated in various intracellular activities such as cell growth, regulation of cell proliferation, skin cell signaling and immune responsiveness. In C. albicans , cAMP production is known to involve in yeast to hyphal formation. In this study, acetylcholine can induce yeast to hyphal form transition and the adenylyl cyclase inhibitor inhibited this transition representing role of cAMP. Inositol phosphate pathway is reported to know in C. albicans . The bioinformatics study exhibits identities and similarities between humans and C. albicans proteins which are involved in inositol phosphate pathway. This study indicates that C. albicans may have a protein like muscarinic receptors. It is suggested that C. albicans Rrp9 protein may have a potential role in yeast to hyphal form conversion.

Acknowledgment

AA and SMK are thankful to Prof. P. Vidyasagar, Vice-chancellor, S.R.T.M. University, Nanded, Maharashtra for the facilities. SMK is also thankful to UGC, New Delhi for infrastructure support under the UGC-SAP-DRS-II program.

References

  1. Bradshaw, Ralph A, Dennis, Edward A (2010) Handbook of cell signaling. Academic Press, Amsterdam, Netherlands.
  2. Papin JA, Hunter T, Palsson BO, Subramaniam S (2005) Reconstruction of cellular signalling networks and analysis of their properties. Nature Rev Molecul Cell Biol 6: 99-111.
  3. Tiwari P, Dwivedi S, Singh MP, Mishra R, Chandy A (2013) Basic and modern concepts on cholinergic receptor: A review.As Pac J Trop Di 3: 413-420.
  4. Caulfield MP, Birdsall NJ (1998) International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.Pharmacol Rev 50: 279-290.
  5. Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10: 69-99.
  6. Goyal R K (1989) Muscarinic receptor subtypes.New Engl J Med 321: 1022-1029.
  7. Ali A, Wakharde A, Karuppayil SM (2017) Rrp9 as a Potential Novel Antifungal Target in Candida albicans: Evidences from In Silico Studies. Med Mycol Open Access 3: 1-5.
  8. Berridge MJ (1987) Inositol trisphosphate and diacylglycerol: two interacting second messengers.Annu Rev Biochem 56: 159-193.
  9. Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361: 315-325.
  10. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, et al. (2002) Molecular Biology of the Cell. ZDA.
  11. Sastry BV, Sadavongvivad C (1978) Cholinergic systems in non-nervous tissues. Pharmacol Rev 30: 65-132.
  12. Eglen RM (2006) Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function.Auton Autac Pharmacol 26: 219-233.
  13. Grando SA, Kawashima K, Kirkpatrick CJ, Wessler I (2007) Recent progress in understanding the non-neuronal cholinergic system in humans. Life Sci 80: 2181-2185.
  14. Wessler I, Kirkpatrick CJ (2008) Acetylcholine beyond neurons: The non‐neuronal cholinergic system in humans.Brit J Pharmacol 154: 1558-1571.
  15. Shah N, Khurana S, Cheng K, Raufman JP (2009) Muscarinic receptors and ligands in cancer.Amer J Physiol Cell Physiol 296: C221-C232.
  16. Volpicelli LA, Levey AI (2004) Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus.Progr Brain Res 145: 59-66.
  17. Fisher A (2008) Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease. Neurotherapeutics 5: 433-442.
  18. Dabrowa NINA, Taxer SSS, Howard DH (1976) Germination of Candida albicans induced by proline.Infect Immun 13: 830-835.
  19. Mattia E, Carruba G, Angiolella L, Cassone A (1982) Induction of germ tube formation by N-acetyl-D-glucosamine in Candida albicans: Uptake of inducer and germinative response.J bacterial 152: 555-562.
  20. ODDS FC. (EDITOR) (1988) Morphogenesis in Candida with special reference to C.albicans. In Candida and Candidiasis, London: Bailliere Tindal. UK: 42-59.
  21. Odds FC, Kerridge D (1985) Morphogenesis in Candida albicans. Crit Rev Microbiol 12: 45-93.
  22. Ernst JF (2000) Transcription factors in Candida albicans-environmental control of morphogenesis.Microbiology 146: 1763-1774.
  23. Hudson DA, Sciascia QL, Sanders RJ, Norris GE, Edwards PJ, et al. (2000) Identification of the dialysable serum inducer of germ-tube formation in Candida albicans.Microbiology 150: 3041-3049.
  24. Biswas S, Van Dijck P, Datta A (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans.Microbio Molecul Biol Rev 71: 348-376.
  25. Brown AJP, Argimon S, Gow NAR (2007) Signal transduction and morphogenesis in Candida albicans. InBiology of the Fungal Cell. Springer Berlin Heidelberg. Germany, 167-194.
  26. Whiteway M, Bachewich C (2007) Morphogenesis in Candida albicans. Annu Rev Microbiol 61: 529-553.
  27. Feng Q, Summers E, Guo B, Fink G (1999) Ras signaling is required for serum-induced hyphal differentiation in Candida albicans.J Bacteriol 181: 6339-6346.
  28. Leberer E, Harcus D, Dignard D, Johnson L, Ushinsky S, et al. (2001) Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans.Molecul Microbiol 42: 673-687.
  29. Chauhan NM, Raut JS, Karuppayil SM (2011) A morphogenetic regulatory role for ethyl alcohol in Candida albicans.Mycoses 54: e697-e703.
  30. Hogan DA, Sundstrom P (2009) The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans.Future Microbiology 4: 1263-1270.
  31. Awad A, Archana W, Karuppayil SM (2017) Muscarinic acetylcholine receptor agonists and antagonists regulate yeast to hyphal form transition in Candida albicans. Ameri J Clin Microbiol Antimicro.
  32. Roy BG, Datta A (1987) A calmodulin inhibitor blocks morphogenesis in Candida albicans.FEMS Microbiol Lett 41: 327-329.
  33. Schatzman RC, Wise BC, Kuo JF (1981) Phospholipid-sensitive calcium-dependent protein kinase: inhibition by antipsychotic drugs. Biochem Biophy Res Commun 98: 669-676.
  34. Gadd GM, Foster SA (1997) Metabolism of inositol 1, 4, 5-trisphosphate in Candida albicans: Significance as a precursor of inositol polyphosphates and in signal transduction during the dimorphic transition from yeast cells to germ tubes.Microbiology 143: 437-448.
  35. Sato T, Ueno Y, Watanabe T, Mikami T, Matsumoto T (2004) Role of Ca2+/calmodulin signaling pathway on morphological development of Candida albicans.Biologic Pharmaceu Bull 27: 1281-1284.
  36. Hoyer LL, Payne TL, Bell M, Myers AM, Scherer S (1998) Candida albicans ALS3 and insights into the nature of the ALS gene family. Curr Genet 33: 451-459.
  37. Fu Y, Ibrahim AS, Sheppard DC, Chen YC, French SW, et al. (2002) Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentationpathway.Molecul Microbiol 44: 61-72.
  38. Satyanarayana T, Kunze G (2009) Yeast biotechnology: Diversity and applications. Dordrecht: Springer: 639-641.
Citation: Ali A, Karuppayil SM (2018) Acetylcholine Induces Yeast to Hyphal form Transition in Candida albicans. Fungal Genom Biol 8:154.

Copyright: ©2018 Ali A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top